formylmethionyl-leucyl-phenylalanine methyl ester has been researched along with pyrazole in 1 studies
| Studies (formylmethionyl-leucyl-phenylalanine methyl ester) | Trials (formylmethionyl-leucyl-phenylalanine methyl ester) | Recent Studies (post-2010) (formylmethionyl-leucyl-phenylalanine methyl ester) | Studies (pyrazole) | Trials (pyrazole) | Recent Studies (post-2010) (pyrazole) |
|---|---|---|---|---|---|
| 67 | 1 | 6 | 1,152 | 0 | 596 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brullo, C; Bruno, O; Selvatici, R; Spisani, S | 1 |
1 other study(ies) available for formylmethionyl-leucyl-phenylalanine methyl ester and pyrazole
| Article | Year |
|---|---|
N-Aryl-2-phenyl-2,3-dihydro-imidazo[1,2-b]pyrazole-1-carboxamides 7-substituted strongly inhibiting both fMLP-OMe- and IL-8-induced human neutrophil chemotaxis.
Topics: Chemotaxis; Humans; Inhibitory Concentration 50; Interleukin-8; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pyrazoles; Structure-Activity Relationship | 2012 |